Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ICAD Inc (NASDAQ:ICAD)

3.85
Delayed Data
As of Sep 04
 -0.07 / -1.79%
Today’s Change
2.95
Today|||52-Week Range
11.63
-58.02%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$61.6M

Company Description

iCAD, Inc. is a provider of advanced image analysis and workflow solutions for the early identification of cancer. The company operates its business through two segments: Cancer Detection and Cancer Therapy. The Cancer Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, a comprehensive range of high-performance, upgradeable Computer-Aided Detection systems and workflow solutions for mammography, Magnetic Resonance and Computed Tomography CT. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. iCAD was founded in 1984 and is headquartered in Nashua, NH.

Contact Information

iCAD, Inc.
98 Spit Brook Road
Nashua New Hampshire 03062
P:(603) 882-5200
Investor Relations:
(603) 431-7967

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Kenneth M. FerryChief Executive Officer & Director
Kevin C. BurnsPresident, COO, CFO, Secretary, Treasurer & EVP
Jonathan GoSenior Vice President-Research & Development
John A. DeLuciaVP-Regulatory Affairs & Clinical Affairs
Kamal C. GogineniSenior Vice President-Oncology Solutions